Bachelard H, Harland D, Gardiner S M, Kemp P A, Bennett T
Department of Physiology & Pharmacology, Medical School, Queen's Medical Centre, Nottingham, U.K.
Neuroscience. 1992;47(4):941-57. doi: 10.1016/0306-4522(92)90042-z.
The cardiovascular effects of noradrenaline bilaterally injected into the hypothalamic paraventricular nuclei were investigated in conscious, unrestrained Long-Evans rats and homozygous, vasopressin-deficient Brattleboro rats, chronically instrumented with pulsed Doppler probes for measurement of regional haemodynamics. In Long-Evans rats, incremental doses of noradrenaline (0.01-10 nmol) caused dose-related increases in blood pressure and a substantial, dose-related, superior mesenteric vasoconstriction. These changes were accompanied by bradycardia and reductions in renal and hind-quarter vascular conductances. In Brattleboro rats, noradrenaline (10 nmol) had no effect on blood pressure, heart rate, or renal or superior mesenteric vascular conductances. However, there was a slight vasodilatation in the vascular bed of the hindquarters. In Long-Evans rats, intravenous pretreatment with phentolamine had no effect on the bradycardia but partly inhibited the pressor response to noradrenaline injected into the paraventricular nuclei. These effects were associated with a smaller superior mesenteric vasoconstriction and an abolition of the vasoconstriction in the hindquarters. Combined intravenous pretreatment with phentolamine and propranolol had no effect on the heart rate or pressor responses to noradrenaline injected into the paraventricular nuclei, but reduced the superior mesenteric vasoconstriction, potentiated the vasoconstriction in the hindquarters and eliminated the renal vasoconstriction. These results suggest that, in untreated Long-Evans rats, alpha-adrenoceptor-mediated constriction in the mesenteric vascular bed and beta-adrenoceptor-mediated dilatation in the vascular bed of the hindquarters have important influences on the pressor response to noradrenaline injected into the paraventricular nuclei. In the presence of the vasopressin V1-receptor antagonist, d(CH2)5[Tyr(Et)]DAVP, the pressor and heart rate responses to noradrenaline injected into the paraventricular nuclei were abolished, as were the vasoconstrictions in the renal, superior mesenteric and hindquarter vascular beds. Together these results suggest an interaction between the sympathoadrenal system and vasopressin-mediated mechanisms in the cardiovascular responses to noradrenaline injected bilaterally into the paraventricular nuclei of conscious, untreated rats.
在清醒、无束缚的Long-Evans大鼠和纯合的、缺乏血管加压素的Brattleboro大鼠中,研究了双侧注入下丘脑室旁核的去甲肾上腺素对心血管系统的影响。这些大鼠长期植入脉冲多普勒探头,用于测量局部血流动力学。在Long-Evans大鼠中,递增剂量的去甲肾上腺素(0.01 - 10 nmol)导致血压呈剂量相关升高,以及肠系膜上动脉出现显著的、剂量相关的血管收缩。这些变化伴有心动过缓以及肾和后肢血管传导性降低。在Brattleboro大鼠中,去甲肾上腺素(10 nmol)对血压、心率或肾或肠系膜上血管传导性没有影响。然而,后肢血管床出现轻微血管扩张。在Long-Evans大鼠中,酚妥拉明静脉预处理对心动过缓没有影响,但部分抑制了注入室旁核的去甲肾上腺素引起的升压反应。这些效应与较小的肠系膜上血管收缩以及后肢血管收缩的消除有关。酚妥拉明和普萘洛尔联合静脉预处理对心率或注入室旁核的去甲肾上腺素引起的升压反应没有影响,但减少了肠系膜上血管收缩,增强了后肢血管收缩并消除了肾血管收缩。这些结果表明,在未处理的Long-Evans大鼠中,肠系膜血管床中α-肾上腺素能受体介导的收缩和后肢血管床中β-肾上腺素能受体介导的扩张对注入室旁核的去甲肾上腺素的升压反应有重要影响。在存在血管加压素V1受体拮抗剂d(CH2)5[Tyr(Et)]DAVP的情况下,注入室旁核的去甲肾上腺素引起的升压和心率反应被消除,肾、肠系膜上和后肢血管床的血管收缩也被消除。这些结果共同表明,在清醒、未处理的大鼠中,双侧注入室旁核的去甲肾上腺素所引起的心血管反应中,交感肾上腺系统与血管加压素介导的机制之间存在相互作用。